Clinical Trial

Bladder Overactivity and Post-Botulinum Toxin Telemonitoring

Study acronym: VESIC@HOME
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 30, 2026 (before its estimated March 2, 2026 completion). Its status may not reflect the trial's current state.
Summary
Prospective, randomized, controlled, single-center study to compare the feasibility of home monitoring for patients receiving intradetrusor botulinum toxin injections with that of the usual hospital-based follow-up.
Trial Details
NCT Number NCT07379372
Lead Sponsor University Hospital, Grenoble
Conditions Overactive Bladder
Enrollment 112 participants
Start Date 2026-03-02
Primary Completion 2026-03-02 (estimated)
Study Completion 2031-03-02 (estimated)
Updated on ClinicalTrials.gov 2026-01-30